NCT04544891View on ClinicalTrials.gov

TREM-1 Pathway Activation in COVID-19

CompletedOBSERVATIONAL
Enrollment

830

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

March 1, 2022

Study Completion Date

March 1, 2022

Conditions
Covid19
Interventions
OTHER

blood sampling

Blood will be collected every 3 days until Day 28, discharge, or death

Trial Locations (2)

87042

CHRU Limoges, Limoges

Unknown

Central hospital, Nancy

Sponsors

Collaborators (1)

Inotrem
All Listed Sponsors
collaborator

University Hospital, Limoges

OTHER

collaborator

Inotrem

INDUSTRY

lead

Central Hospital, Nancy, France

OTHER